Hyperfine, Inc. (HYPR)
1.15
-0.01
(-0.86%)
USD |
NASDAQ |
Feb 20, 16:00
1.155
0.00 (0.00%)
After-Hours: 20:00
Hyperfine EPS Diluted (Quarterly) : -0.1394 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | -0.2572 |
| Celldex Therapeutics, Inc. | -1.009 |
| Plus Therapeutics, Inc. | -0.0412 |
| Atossa Therapeutics, Inc. | -1.009 |
| Abeona Therapeutics, Inc. | -0.0952 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.02M |
| Revenue (Quarterly) | 3.437M |
| Total Expenses (Quarterly) | 14.46M |
| Enterprise Value | 89.90M |
| Gross Profit Margin (Quarterly) | 53.77% |
| Profit Margin (Quarterly) | -320.6% |
| Earnings Yield | -45.57% |
| Normalized Earnings Yield | -44.81 |